Clinical Outcomes of Infrapopliteal Angioplasty in Patients With Critical Limb Ischemia.
10.4070/kcj.2012.42.4.259
- Author:
Hyeon Min RYU
1
;
Jung Sun KIM
;
Young Guk KO
;
Myeong Ki HONG
;
Yangsoo JANG
;
Donghoon CHOI
Author Information
1. Gumi CHA Medical Center, CHA University, Gumi, Korea.
- Publication Type:Original Article
- Keywords:
Ischemia;
Limb salvage;
Tibial arteries;
Peroneal arteries;
Angioplasty
- MeSH:
Angioplasty;
Extremities;
Follow-Up Studies;
Freedom;
Humans;
Ischemia;
Limb Salvage;
Stroke;
Tibial Arteries
- From:Korean Circulation Journal
2012;42(4):259-265
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND OBJECTIVES: With recent advances in equipment and techniques, infrapopliteal angioplasty has shown results that are comparable to those of surgical bypass in patients with critical limb ischemia (CLI). In this study, we evaluated the efficacy and the feasibility of infrapopliteal angioplasty in patients with CLI. SUBJECTS AND METHODS: Between March 2002 and May 2008, infrapopliteal angioplasty was performed on 118 limbs of 101 patients (79 males; mean age 66 years) with CLI (Rutherford category 4, 5 or 6). Freedom from reintervention, limb salvage, and overall survival were analyzed. RESULTS: The median follow-up duration was 30 months. Initial technical and clinical success rates were 69.5% and 83.1%, respectively. No major complication requiring surgical intervention developed after angioplasty. Among 82 limbs with initial technical success, the rate of freedom from any reintervention at 2 years was 70.7% and that from limb salvage was 97.6%. Young age and Rutherford category 6 at initial presentation were independent predictors associated with poor 2 year primary patency in these patients with CLI. Overall survival at 1 year was 86.4% and that at 2 years 76.3%. A history of cerebrovascular accident was an independent predictor associated with poor 2 year survival in these patients. CONCLUSION: Infrapopliteal angioplasty as a primary choice of treatment in CLI patients showed favorable clinical outcomes and feasibility.
